Inhibrx Inc
NASDAQ:INBX
Inhibrx Inc
NASDAQ:INBX
Price:
74.13
USD
-4.01%
Market Cap:
$1.1B
Balance Sheet
Balance Sheet Decomposition
Inhibrx Inc
Inhibrx Inc
Balance Sheet Decomposition is not available for
Inhibrx Inc
Inhibrx Inc
Balance Sheet
Inhibrx Inc
Inhibrx Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
14
|
2
|
12
|
129
|
131
|
274
|
278
|
0
|
|
| Cash |
14
|
2
|
12
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
129
|
131
|
274
|
278
|
0
|
|
| Total Receivables |
1
|
1
|
0
|
1
|
1
|
0
|
1
|
0
|
|
| Accounts Receivables |
0
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Receivables |
1
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Other Current Assets |
1
|
3
|
4
|
3
|
7
|
6
|
17
|
7
|
|
| Total Current Assets |
15
|
6
|
16
|
132
|
139
|
281
|
295
|
160
|
|
| PP&E Net |
2
|
3
|
11
|
11
|
10
|
7
|
9
|
14
|
|
| PP&E Gross |
2
|
3
|
11
|
11
|
10
|
7
|
9
|
0
|
|
| Accumulated Depreciation |
1
|
2
|
2
|
3
|
4
|
6
|
7
|
0
|
|
| Other Long-Term Assets |
0
|
2
|
0
|
0
|
2
|
3
|
3
|
7
|
|
| Total Assets |
17
N/A
|
10
-42%
|
27
+165%
|
144
+442%
|
151
+5%
|
291
+93%
|
308
+6%
|
181
-41%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
7
|
3
|
14
|
9
|
8
|
11
|
9
|
|
| Accrued Liabilities |
3
|
2
|
6
|
15
|
11
|
19
|
45
|
31
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
5
|
6
|
4
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
2
|
8
|
3
|
2
|
0
|
0
|
0
|
|
| Total Current Liabilities |
9
|
16
|
21
|
31
|
23
|
28
|
56
|
41
|
|
| Long-Term Debt |
10
|
4
|
30
|
29
|
71
|
202
|
207
|
0
|
|
| Minority Interest |
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
10
|
8
|
5
|
3
|
1
|
6
|
|
| Total Liabilities |
25
N/A
|
20
-20%
|
61
+201%
|
68
+13%
|
98
+44%
|
233
+137%
|
264
+13%
|
47
-82%
|
|
| Equity | |||||||||
| Common Stock |
21
|
48
|
60
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
29
|
58
|
94
|
145
|
227
|
372
|
614
|
106
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
221
|
280
|
430
|
657
|
240
|
|
| Total Equity |
8
N/A
|
10
-31%
|
34
-238%
|
76
N/A
|
52
-31%
|
58
+11%
|
44
-24%
|
134
+205%
|
|
| Total Liabilities & Equity |
17
N/A
|
10
-42%
|
27
+165%
|
144
+442%
|
151
+5%
|
291
+93%
|
308
+6%
|
181
-41%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
37
|
37
|
37
|
38
|
39
|
44
|
47
|
14
|
|
Switch to:
Switch to:
See Also
Discover More
